Tag: Covid-19 and Antibody Testing

Hackensack Meridian Health Convalescent Plasma Work for COVID-19 Treatments Enters Next Phase of Study

sarah JonasFeature

The new Phase 2 study is for infusing this potentially valuable serum into patients with early-stage COVID-19 infection who have at least one major risk factor for serious disease, in an outpatient setting. The goal is to treat the patients in the first 96 hours – with the aim to prevent hospitalization entirely.

UNH Strives for Safety: Testing for COVID-19 in State-of-The-Art Lab

sarah JonasAnnouncement

The University of New Hampshire is testing students for the coronavirus in a newly created cutting-edge laboratory located on the Durham campus using self-swabbing home kits developed at UNH. The lab is exclusively testing for COVID-19 and will play a key role in the university’s commitment to extensively monitor the student population and quickly identify and prevent any spread of the virus and help provide a safe environment for students, faculty, staff and the community.

Study Reveals New Targets for Next-Generation COVID-19 Vaccines and Tests, Beyond Antibodies

sarah JonasResearch Results

This clinical trial increased an understanding of how T cells mount a response to COVID-19 infection. These findings pave the way for diagnostic tests that detect COVID immunity based on T cells instead of antibodies. Research demonstrates that generating neutralizing antibodies rather than T cells, may not be sufficient for long-term immunity. New discoveries suggest that vaccines will need to incorporate T cell targets to generate lasting COVID-19 immunity.